Abstract. Transient growth hormone deficiency (GHD) is occasionally found in prepubertal individuals, and this phenomenon has been variously interpreted. Sex steroids enhance GH secretion; however, the cut-off values of provocative GH tests are not modified according to the physiological changes. Physiological changes in sex steroid levels are thought to cause the image of transient GHD. In addition, the reproducibility of provocative GH tests makes the interpretation complicated. We experienced a case of a boy with short stature who had undergone provocative GH tests at three different times: childhood (5 and 7 years old), before puberty (12 years old), and in adolescence (15 years old). Although the responses of GH in his childhood and adolescence were within the normal range, his prepubertal GH response was extremely low, as if he had "complete" GHD (peak GH: insulin test, 0.60 ng/ml; clonidine test, 0.78 ng/ml). No morphological changes were observed in the pituitary gland or hypothalamus on MRI. The level of insulin-like growth factor 1 was in the normal range for his age at this time. Here, we report the clinical course and endocrinological data of this case, and suggest that transient GHD is caused not only by the physiological effects of sex steroids but also by certain mechanisms that actively reduce GH secretion.
PHYSIOLOGICAL growth hormone (GH) secretion is highly variable, and it is difficult to evaluate GH secretion by a single serum level of GH [1] [2] [3] . There is a general consensus that the diagnosis of impaired GH secretion can be confirmed only if subnormal GH secretion is observed in stimulation tests. However, there are problems with these tests in that the response of GH may be influenced by the age, sex, and pubertal stage of a patient [1] [2] [3] . Thus, these problems should be considered when evaluating the results of GH stimulation tests. Certain studies have reported that in patients with delayed puberty, transient partial growth hormone deficiency (GHD) is occasionally seen in GH stimulation tests [4] [5] [6] [7] [8] [9] [10] . The cause of this phenomenon is unclear, and it complicates the clinical diagnosis of short stature [11] .
Interpretation of transient GHD is controversial. Many studies of transient GHD have been conducted in two different periods, before and after puberty [4, 6, 8, 9] . At these times, it should be considered that sex steroids affect GH secretion; however, the cut-off values of provocative tests are not modified according the physiological changes. The low reproducibility of provocative tests is another problem. Loche et al. do not support the concept that transient GHD subsides under the influence of pubertal secretion of sex steroids [12] .
Here, we report a case of a boy whose response to GH stimulation tests was very low at 12 years of age, although the level of insulin-like growth factor 1 (IGF-1) was normal for his age. His responses to GH stimulation tests performed in childhood and after puberty were normal. We concluded that the patient had transient GHD in the prepubertal stage.
Case Report
A 3-year-old boy was referred to our hospital because of short stature. His height was 85.0 cm (-2.30 SD) (Fig. 1) . The heights of his parents were 163 cm (father) and 148 cm (mother). His perinatal history was normal (cephalic delivery, 42 weeks, 3,110 g, mild jaundice). At 7 years and 3 months of age, his height velocity showed a decrease and his height was 107.5 cm (-2.75 SD). We performed GH stimulation tests at this time. His GH response was within the normal range (peak GH: insulin test, 27 ng/ml; arginine test, 17 ng/ml; GH-releasing factor (GRF) test, 76 ng/ ml) ( Table 1) .
Based on these results, we observed him without GH therapy. However, at the age of 12 years and 7 months, his height was 130.2 cm (-2.80 SD) and there were no signs of puberty. When we re-examined the patient more precisely, it was found that the GH response was extremely low (insulin test, 0.62 ng/ml; clonidine test, 0.78 ng/ml; GRF test, 7.89 ng/ml) (Table 1). The GH concentration in urine collected at night was below the detectable range (<5 pg/ml). These data suggested that the secretion of GH was severely abolished. To identify the cause of GHD, we investigated the secretion of other anterior pituitary hormones and examined the morphological examination of the hypothalamus and pituitary gland. We found no abnormalities on enhanced MRI. Antipituitary antibodies were not detected. We excluded the possibilities of brain tumor and lymphocytic hypophysitis. Gonadotropin secretion was at the level of the pubertal stage without physical pubertal signs (pubic hair: Tanner stage I, genitalia: Tanner stage I, testis volume: 3 ml). The serum testosterone level was 20 ng/dl. The secretion of other anterior pituitary hormones was maintained. Despite the impairment of GH secretion, the serum level of IGF-1 was within the normal range at 294 ng/ml.
Although we suspected that this phenomenon was due to physiological transient GHD in the prepubertal stage, we could not exclude the possibility that he had permanent GHD because of the extremely low GH response. Thus, the patient was given GH supplementation therapy. Soon after, a growth spurt and physical signs of puberty were observed. GH therapy was discontinued when the patient was 15 years and 2 months old, and his final height was 158.9 cm. After six months (at the age of 15 years and 8 months), we again evaluated his GH secretion. The GH response to insulin stimulation was within the normal range, with a peak GH of 54.7 ng/ml (Table 1) . These results suggest that the impaired GH secretion was a physiological transient phenomenon in the prepubertal stage.
Discussion
Certain studies have reported transient GHD in pre- pubertal individuals [4, 6, 8, 9] . Most patients in these studies had transient partial GHD, and the GHD was not severe. In our case, the data indicated that GH secretion was severely abolished. We examined the patient thoroughly and excluded the presence of other conditions. Despite intensive investigations, we could not determine the origin of the GHD. After the end of GH supplementation therapy, we again performed GH stimulation tests, and the GH response had recovered enough to be within the normal range. We concluded that the GH impairment was a transient physiological phenomenon.
The mechanisms of the prepubertal impairment of GH secretion in stimulation tests are unclear. Considering the mechanisms of transient GHD, our case was interesting in two aspects.
First, transient GHD in this case could not be explained adequately by the effect of sex steroids or the reproducibility of GH stimulation tests. In many reports of transient GHD, GH stimulation tests were performed at only two different times, before puberty and after the onset of puberty [4, 6, 8, 9] . It is well known that sex steroids induce GH secretion [5, 13, 14] , and subjects who are diagnosed with GHD before puberty often display normal GH secretion at the end of puberty [6, 8, 9] . In our case, however, GH secretion in stimulation tests was in the normal range in his childhood. This suggests that there are certain active mechanisms that reduce GH secretion other than physiological shortage of sex steroids. Moreover, at this time, the gonadotropins response to LHRH and serum testosterone levels were slightly elevated. In certain studies, it is recommended that GH secretion should be re-evaluated in puberty or on priming with sex steroids [15] [16] [17] [18] in subjects with isolated GHD without any morphological abnormality in the pituitary gland. We did not perform priming with sex steroids because of the clinical course and certain limitations of this procedure (it is not physiologic or standardized, and the cut-off limits are not available) [12] . We performed multiple GH stimulation tests in each period, and excluded the possibility that transient GHD seen in this case was due to the low reproducibility of the tests. Second, it is reported that decreased GH secretion may be ascribed to reduced secretion of growth hormone-releasing hormone (GHRH), which is reversible with the onset of puberty, without any change in circulating somatostatin levels [19] . In our patient, the GH response to GHRH was also reduced. This would suggest that chronic shortage of intrinsic GHRH may cause poor response to exogenous GHRH. However we cannot exclude the possibility that impaired GH secretion may have a cause other than reduced GHRH secretion. To distinguish these two possibilities, repeated exogenous GHRH stimulation may be useful. If GH secretion recovers, chronic shortage of intrinsic GHRH is suggested.
Transient GHD may be a clinical pitfall in the diagnosis of GHD [11] , and it is reported that IGF-1 levels are useful in differentiating transient GHD from pathological GHD. In our case, despite profound impairment of GH secretion, IGF-1 levels were maintained within the normal range for his age. The preserved IGF-1 levels indicated that physiological GH secretion was maintained (Fig. 2) . However, it should be noted that, generally, IGF-1 alone is not sufficient to diagnose GHD with specificity and sensitivity. To distinguish transient GHD from permanent GHD, careful evaluation is necessary.
It is reported that urinary GH measurement in shortstature early pubertal boys may help to exclude GHD [20] . In our case, the urinary GH concentration was below the measurable range and thus was not useful in distinguishing transient GHD.
In conclusion, we have presented a case of transient prepubertal GHD with extremely low GH responses to stimulation tests. Transient GHD may be a clinical pitfall; however, it is suggested that serum IGF-1 levels are helpful in distinguishing transient GHD from pathological permanent GHD. From the experience of this case, we suggest that in addition to the physiological effects of sex steroids, transient GHD is caused by some other mechanisms that reduce GH secretion. Changes in serum IGF-1 levels and peak levels of GH on insulin tolerance test.
